Search | Page 17 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Pasireotide in Prevention of GI Toxicity

    ... Consenting 4-6/6 antigen matched stem cell donor or genetically matched unrelated bone marrow or adult stem cell donor. 18 years of age or ...

    Clinical Trial last updated 06/06/2016 - 10:41am.

  2. Intra-Osseous Co-Transplant of UCB and hMSC

    ... This clinical trial studies intra-osseous donor umbilical cord blood and mesenchymal stromal cell co-transplant in ... (defined as matched in HLA A, B, C, and DRB1) related or unrelated donors Cord Blood Units available through NMDP with the ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  3. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... hematopoietic stem cell transplantation from a related or unrelated HLA matched donor. The effect of 5-azacytidine on global gene methylation will be ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  4. New York Blood Center National Cord Blood Program

    ... candidates for a bone marrow transplant from an unrelated marrow donor. The outcome of transplantation is obtained to assess cord blood myeloid ...

    Clinical Trial last updated 06/13/2016 - 1:43pm.

  5. Transplantation Update

    ... patients for stem cell transplants regardless of who the donor is or the source of stem cells used.  There has been a focus on ... 97 aplastic anemia patients who received transplants from unrelated donors after having failed immunosuppressive therapy, this study was ...

    Interview last updated 05/14/2015 - 2:42pm.

  6. Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

    ... event-free survival to 30% to 50% in the alternative donor (matched unrelated, partially matched family member) transplantation. Although an ...

    Clinical Trial last updated 04/08/2016 - 11:25pm.

  7. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... is also designed to block your body's ability to reject the donor's bone marrow cells. Melphalan and busulfan are designed to bind to ... failure. The source can be autologous, related or unrelated. Exclusion ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.

  8. Allogenic stem cell transplantation for older patients with AML and MDS

    ... The term “allogeneic” refers to a transplant from a donor who is someone other than himself or herself; rather the donor is someone with a different immune system such as a sibling or an unrelated person. This type of transplant works by supplying the patient with ...

    Research Review last updated 05/02/2016 - 9:31am.

  9. 2013 Scholarships Awarded to Special Group of Young People

    ... dollars and registered more than 40 people to the marrow donor registry. The experience I have gained through this drive has made me ... says the Elsmere, Kentucky native. In January 2012, an unrelated donor was found and Kayla went through a bone marrow transplant ...

    Page last updated 06/24/2015 - 10:22am.

  10. Abatacept Reduced Intensity for Non-Malignant Diseases (Aba NMD)

    ... mortality from graft versus host disease (GVHD), driven by donor T cells recognizing and reacting against disparate host antigens. This ... mofetil, to improve disease-free survival after unrelated hematopoietic stem cell transplantation (HSCT) using low dose total ...

    Clinical Trial last updated 04/27/2016 - 2:40pm.